← Back
Data updated: Jun 28, 2026
STERISCIENCE PTE. LIMITED
Pharma Pharmaceuticals
STERISCIENCE PTE. LIMITED is a pharmaceutical company with 1 FDA-approved products.
-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
STERISCIENCE PTE. LIMITED's Key Drugs
STERISCIENCE PTE. LIMITED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
STERISCIENCE PTE. LIMITED's Recent FDA Approvals
New NDA/BLA approvals for STERISCIENCE PTE. LIMITED over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
STERISCIENCE PTE. LIMITED's Therapeutic Areas
Disease areas where STERISCIENCE PTE. LIMITED has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
STERISCIENCE PTE. LIMITED Pipeline Snapshot
Active clinical trials for STERISCIENCE PTE. LIMITED across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 1